Your browser doesn't support javascript.
loading
MiR-181a-2-3p as a potential diagnostic and prognostic marker for myelodysplastic syndrome.
Liang, Xiaolin; Shi, Zeyan; Huang, Xiaoke; Wan, Chengyao; Zhu, Shanhu; Wu, Meiqing; Li, Zhongqing; Tang, Zhongyuan; Li, Jing; Zhao, Weihua; Luo, Jun; Liu, Zhenfang.
Afiliação
  • Liang X; Hematology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
  • Shi Z; Key Laboratory of Hematology, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
  • Huang X; Hematology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
  • Wan C; Key Laboratory of Hematology, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
  • Zhu S; Hematology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
  • Wu M; Hematology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
  • Li Z; Hematology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
  • Tang Z; Hematology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
  • Li J; Hematology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
  • Zhao W; Hematology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
  • Luo J; Hematology Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
  • Liu Z; Key Laboratory of Hematology, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Hematology ; 27(1): 1246-1252, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36444993

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Segunda Neoplasia Primária / MicroRNAs Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Segunda Neoplasia Primária / MicroRNAs Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article